PTJ
CVAC

Paul Tudor Jones’s CureVac CVAC Stock Holding History

Paul Tudor Jones’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,070
Closed -$30.5K – 2395
2024
Q1 		$30.5K Sell
10,070
-2,212
-18% -$7.76K ﹤0.01% 2127
2023
Q4 		$51.7K Buy
+12,282
New +$66.6K ﹤0.01% 2266
2023
Q3 		– Sell
-21,454
Closed -$224K – 2381
2023
Q2 		$224K Buy
+21,454
New +$192K ﹤0.01% 2163
2023
Q1 		– Sell
-14,762
Closed -$89K – 2505
2022
Q4 		$89K Buy
+14,762
New +$109K ﹤0.01% 2228
2022
Q3 		– Sell
-22,335
Closed -$304K – 2371
2022
Q2 		$304K Buy
22,335
+9,628
+76% +$159K 0.01% 1557
2022
Q1 		$249K Buy
12,707
+3,400
+37% +$67.9K 0.01% 1651
2021
Q4 		$319K Buy
+9,307
New +$374K 0.01% 1797
2021
Q3 		– Sell
-2,972
Closed -$218K – 2507
2021
Q2 		$218K Sell
2,972
-59
-2% -$5.9K ﹤0.01% 1460
2021
Q1 		$277K Buy
+3,031
New +$294K 0.01% 1333

Other funds holding CVAC

Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Paul Tudor Jones's CVAC Position: Q2 2024 in Review

Paul Tudor Jones sold out of CureVac (CVAC) in Q2 2024, closing a stake of 10,070 shares — an estimated $30.5K sold.

Paul Tudor Jones first reported a position in CVAC in Q1 2021 and held it in 9 quarters. The position peaked at $319K in Q4 2021. 87 funds tracked by Wall St. Rank hold CVAC as of Q2 2024.

  • Paul Tudor Jones reported no remaining CureVac position as of Q2 2024 after selling out during the quarter.
  • Paul Tudor Jones sold 10,070 CureVac shares in Q2 2024, an estimated $30.5K.
  • Paul Tudor Jones first reported a position in CureVac in Q1 2021 and held it in 9 quarters.
  • Paul Tudor Jones's CureVac position peaked at $319K in Q4 2021.
  • 87 funds tracked by Wall St. Rank held CureVac as of Q2 2024.

Based on Tudor Investment Corp's 13F filing for Q2 2024, filed 14 Aug 2024.